> top > projects > sentences > docs > PubMed:16311883 > annotations
sentences Home  

PubMed:16311883 JSONTXT 45 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-73 Sentence denotes Serum hyaluronidase aberrations in metabolic and morphogenetic disorders.
TextSentencer_T1 0-73 Sentence denotes Serum hyaluronidase aberrations in metabolic and morphogenetic disorders.
T1 0-73 Sentence denotes Serum hyaluronidase aberrations in metabolic and morphogenetic disorders.
TextSentencer_T2 74-188 Sentence denotes Hyaluronidases are endo-glycosidases that degrade both hyaluronan (hyaluronic acid) (HA) and chondroitin sulfates.
TextSentencer_T2 74-188 Sentence denotes Hyaluronidases are endo-glycosidases that degrade both hyaluronan (hyaluronic acid) (HA) and chondroitin sulfates.
T2 74-188 Sentence denotes Hyaluronidases are endo-glycosidases that degrade both hyaluronan (hyaluronic acid) (HA) and chondroitin sulfates.
TextSentencer_T3 189-326 Sentence denotes Deficiency of hyaluronidase activity has been predicted to result in a phenotype similar to that observed in mucopolysaccharidosis (MPS).
TextSentencer_T3 189-326 Sentence denotes Deficiency of hyaluronidase activity has been predicted to result in a phenotype similar to that observed in mucopolysaccharidosis (MPS).
T3 189-326 Sentence denotes Deficiency of hyaluronidase activity has been predicted to result in a phenotype similar to that observed in mucopolysaccharidosis (MPS).
TextSentencer_T4 327-566 Sentence denotes In the present study, we surveyed a variety of patients with phenotypes similar to those observed in MPS, but without significant mucopolysacchariduria to determine if some are based on aberrations in serum hyaluronidase (Hyal-1) activity.
TextSentencer_T4 327-566 Sentence denotes In the present study, we surveyed a variety of patients with phenotypes similar to those observed in MPS, but without significant mucopolysacchariduria to determine if some are based on aberrations in serum hyaluronidase (Hyal-1) activity.
T4 327-566 Sentence denotes In the present study, we surveyed a variety of patients with phenotypes similar to those observed in MPS, but without significant mucopolysacchariduria to determine if some are based on aberrations in serum hyaluronidase (Hyal-1) activity.
TextSentencer_T5 567-704 Sentence denotes The study included patients with well-characterized dysmorphic disorders occurring on genetic basis, as well as those of unkown etiology.
TextSentencer_T5 567-704 Sentence denotes The study included patients with well-characterized dysmorphic disorders occurring on genetic basis, as well as those of unkown etiology.
T5 567-704 Sentence denotes The study included patients with well-characterized dysmorphic disorders occurring on genetic basis, as well as those of unkown etiology.
TextSentencer_T6 705-823 Sentence denotes The purpose of the study was to establish how wide spread were abnormalities in levels of circulating Hyal-1 activity.
TextSentencer_T6 705-823 Sentence denotes The purpose of the study was to establish how wide spread were abnormalities in levels of circulating Hyal-1 activity.
T6 705-823 Sentence denotes The purpose of the study was to establish how wide spread were abnormalities in levels of circulating Hyal-1 activity.
TextSentencer_T7 824-930 Sentence denotes A simple and sensitive semi-quantitative zymographic procedure was used for the determination of activity.
TextSentencer_T7 824-930 Sentence denotes A simple and sensitive semi-quantitative zymographic procedure was used for the determination of activity.
T7 824-930 Sentence denotes A simple and sensitive semi-quantitative zymographic procedure was used for the determination of activity.
TextSentencer_T8 931-1135 Sentence denotes Levels of both beta-N-acetylglucosaminidase and beta-glucuronidase whose activities contribute to the total breakdown of hyaluronan (HA) were also measured, as well as the concentration of circulating HA.
TextSentencer_T8 931-1135 Sentence denotes Levels of both beta-N-acetylglucosaminidase and beta-glucuronidase whose activities contribute to the total breakdown of hyaluronan (HA) were also measured, as well as the concentration of circulating HA.
T8 931-1135 Sentence denotes Levels of both beta-N-acetylglucosaminidase and beta-glucuronidase whose activities contribute to the total breakdown of hyaluronan (HA) were also measured, as well as the concentration of circulating HA.
TextSentencer_T9 1136-1349 Sentence denotes Among 48 patients with bone or connective tissue abnormalities, low levels of Hyal-1 activity were found in six patients compared to levels in 100 healthy donors (2.0-3.2 units/microL vs 6(+/- 1 SE) units/microL).
TextSentencer_T9 1136-1349 Sentence denotes Among 48 patients with bone or connective tissue abnormalities, low levels of Hyal-1 activity were found in six patients compared to levels in 100 healthy donors (2.0-3.2 units/microL vs 6(+/- 1 SE) units/microL).
T9 1136-1349 Sentence denotes Among 48 patients with bone or connective tissue abnormalities, low levels of Hyal-1 activity were found in six patients compared to levels in 100 healthy donors (2.0-3.2 units/microL vs 6(+/- 1 SE) units/microL).
TextSentencer_T10 1350-1652 Sentence denotes These six patients exhibited a wide spectrum of clinical abnormalities, in particular shortened extremities: they included three patients with unknown causes of clinical symptoms, one patient with Sanfilippo disease, one of the seven patients with achondroplasia, and one with hypophosphotemic rickets.
TextSentencer_T10 1350-1652 Sentence denotes These six patients exhibited a wide spectrum of clinical abnormalities, in particular shortened extremities: they included three patients with unknown causes of clinical symptoms, one patient with Sanfilippo disease, one of the seven patients with achondroplasia, and one with hypophosphotemic rickets.
T10 1350-1652 Sentence denotes These six patients exhibited a wide spectrum of clinical abnormalities, in particular shortened extremities: they included three patients with unknown causes of clinical symptoms, one patient with Sanfilippo disease, one of the seven patients with achondroplasia, and one with hypophosphotemic rickets.
TextSentencer_T11 1653-1861 Sentence denotes Normal levels of serum Hyal-1 activities were found in patients with Morquio disease, GM1 gangliosidosis, I cell-disease, 6 of the 7 patients with achondroplasia, Marfan's-syndrome and Ehlers-Danlos syndrome.
TextSentencer_T11 1653-1861 Sentence denotes Normal levels of serum Hyal-1 activities were found in patients with Morquio disease, GM1 gangliosidosis, I cell-disease, 6 of the 7 patients with achondroplasia, Marfan's-syndrome and Ehlers-Danlos syndrome.
T11 1653-1861 Sentence denotes Normal levels of serum Hyal-1 activities were found in patients with Morquio disease, GM1 gangliosidosis, I cell-disease, 6 of the 7 patients with achondroplasia, Marfan's-syndrome and Ehlers-Danlos syndrome.
TextSentencer_T12 1862-1910 Sentence denotes No patient totally lacked serum Hyal-1 activity.
TextSentencer_T12 1862-1910 Sentence denotes No patient totally lacked serum Hyal-1 activity.
T12 1862-1910 Sentence denotes No patient totally lacked serum Hyal-1 activity.
TextSentencer_T13 1911-1996 Sentence denotes Serum HA concentration was elevated in patients with Sanfilippo A and I-cell disease.
TextSentencer_T13 1911-1996 Sentence denotes Serum HA concentration was elevated in patients with Sanfilippo A and I-cell disease.
T13 1911-1996 Sentence denotes Serum HA concentration was elevated in patients with Sanfilippo A and I-cell disease.
TextSentencer_T14 1997-2132 Sentence denotes Determination of serum and leukocyte Hyal-1 and serum HA may be useful to evaluate patients with metabolic and morphogenetic disorders.
TextSentencer_T14 1997-2132 Sentence denotes Determination of serum and leukocyte Hyal-1 and serum HA may be useful to evaluate patients with metabolic and morphogenetic disorders.
T14 1997-2132 Sentence denotes Determination of serum and leukocyte Hyal-1 and serum HA may be useful to evaluate patients with metabolic and morphogenetic disorders.